FI903759A0 - Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering. - Google Patents

Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.

Info

Publication number
FI903759A0
FI903759A0 FI903759A FI903759A FI903759A0 FI 903759 A0 FI903759 A0 FI 903759A0 FI 903759 A FI903759 A FI 903759A FI 903759 A FI903759 A FI 903759A FI 903759 A0 FI903759 A0 FI 903759A0
Authority
FI
Finland
Prior art keywords
administrering
acetylcystein
foer
oral
pharmaceutical composition
Prior art date
Application number
FI903759A
Other languages
English (en)
Inventor
Angelo Carenzi
Dario Chiarino
Antonio Longo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of FI903759A0 publication Critical patent/FI903759A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI903759A 1989-07-27 1990-07-27 Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering. FI903759A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921339A IT1231012B (it) 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac.

Publications (1)

Publication Number Publication Date
FI903759A0 true FI903759A0 (fi) 1990-07-27

Family

ID=11180335

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903759A FI903759A0 (fi) 1989-07-27 1990-07-27 Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.

Country Status (20)

Country Link
US (1) US5080906A (fi)
JP (1) JPH0399012A (fi)
KR (1) KR910002438A (fi)
AU (1) AU625925B2 (fi)
BE (1) BE1003188A4 (fi)
CA (1) CA2021808A1 (fi)
CH (1) CH680190A5 (fi)
DE (1) DE4023774A1 (fi)
DK (1) DK177890A (fi)
FI (1) FI903759A0 (fi)
FR (1) FR2650503B1 (fi)
GB (1) GB2234171B (fi)
GR (1) GR900100569A (fi)
IE (1) IE902627A1 (fi)
IL (1) IL95158A0 (fi)
IT (1) IT1231012B (fi)
NL (1) NL9001714A (fi)
NZ (1) NZ234647A (fi)
SE (1) SE9002500L (fi)
ZA (1) ZA905861B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
JP2001507696A (ja) 1996-12-31 2001-06-12 アンチオキシダント ファーマシューティカルズ コーポレーション グルタチオンの医薬製剤およびその投与方法
FR2803720B1 (fr) 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6114387A (en) * 2000-02-16 2000-09-05 Cutler; Paul Pharmaceutical composition for oral administration of chelating agents
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
US20030162732A1 (en) * 2001-07-05 2003-08-28 Astion Development A/S Combination of aminosugars and cysteine or cysteine derivatives
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021881A1 (it) * 2002-09-04 2004-03-05 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
KR20050104152A (ko) * 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
PL3554491T3 (pl) * 2016-12-15 2023-07-17 Zambon S.P.A. N-acetylocysteina do stosowania jako środek antybakteryjny
PT3829535T (pt) * 2018-07-27 2024-02-06 Icf Srl Composições para prevenção e tratamento de afeções cutâneas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
US4894225A (en) * 1987-03-02 1990-01-16 Cetus Corporation Combination therapy using antitumor immunotoxins with tumor necrosis factor
JPS63290824A (ja) * 1987-05-22 1988-11-28 Sumitomo Chem Co Ltd ウイルス感染症治療剤
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina

Also Published As

Publication number Publication date
FR2650503B1 (fr) 1992-05-29
IL95158A0 (en) 1991-06-10
NL9001714A (nl) 1991-02-18
GR900100569A (el) 1991-12-10
DE4023774A1 (de) 1991-01-31
IE902627A1 (en) 1991-02-27
NZ234647A (en) 1992-02-25
CA2021808A1 (en) 1991-01-28
SE9002500L (sv) 1991-01-28
SE9002500D0 (sv) 1990-07-26
CH680190A5 (fi) 1992-07-15
IT8921339A0 (it) 1989-07-27
US5080906A (en) 1992-01-14
GB2234171B (en) 1993-11-10
IT1231012B (it) 1991-11-08
DK177890A (da) 1991-01-28
GB2234171A (en) 1991-01-30
JPH0399012A (ja) 1991-04-24
AU5993590A (en) 1991-01-31
AU625925B2 (en) 1992-07-16
GB9016256D0 (en) 1990-09-12
ZA905861B (en) 1991-07-31
FR2650503A1 (fr) 1991-02-08
KR910002438A (ko) 1991-02-25
BE1003188A4 (fr) 1992-01-07
DK177890D0 (da) 1990-07-26

Similar Documents

Publication Publication Date Title
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
NL300047I1 (nl) Farmaceutische samenstelling.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
FI903759A0 (fi) Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.
BR8902337A (pt) Composicao oral
IT8920486A0 (it) Composizioni farmaceutiche.
BR8902338A (pt) Composicao oral
DE68908500D1 (de) Dentalzusammensetzung.
DE69012702D1 (de) Dentalzusammensetzung.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A0 (fi) Farmaceutiska kompositioner.
FI872733A0 (fi) Farmaceutiska kompositioner.
BR8903994A (pt) Composicao oral
FI872313A0 (fi) Farmaceutiska kompositioner.
FI883673A0 (fi) Farmaceutiska kompositioner.
FI874414A0 (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
MX11584A (es) Composiciones farmaceuticas
DE68907609D1 (de) Arzneimittelzusammensetzung.
IT1216814B (it) Composizioni farmaceutiche
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
IT8919844A0 (it) Composizioni farmaceutiche.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: ZAMBON GROUP S.P.A.